Cardiac magnetic resonance for early detection and risk stratification of patients with non-compaction cardiomyopathy

European Journal of Heart Failure

Volumn 13, Issue 10, 2011, Pages 1153-1154

  Mavrogeni, Sophie ^a   Bratis, Konstantinos ^a   Kolovou, Genovefa ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM;

BECKER MUSCULAR DYSTROPHY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL DECISION MAKING; COMORBIDITY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; EARLY DIAGNOSIS; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; LATE GADOLINIUM ENHANCEMENT; LETTER; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; VENTRICULAR NONCOMPACTION;

CARDIOMYOPATHIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80053221185     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr112     Document Type: Letter

References (9)

1. Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M. Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail 2011;13:170-176.
2. Willemsen HM, van den Berg MP. A few more pieces in the puzzle of non-compaction cardiomyopathy. Eur J Heart Fail 2011;13:127-129.
3. Alter P, Rupp H. Myocardial fibrosis in left ventricular non-compaction: is late gadolinium enhancement indeed indicative of fibrosis? Eur J Heart Fail 2011;13: 577-578.
4. Martín M, Barriales V, Corros C, Santamarta E. Usefulness of cardiac magnetic resonance imaging in left ventricular non-compaction cardiomyopathy. Eur J Heart Fail 2011;13:577.
5. Lehrke S, Lossnitzer D, Schöb M, Steen H, Merten C, Kemmling H, Pribe R, Ehlermann P, Zugck C, Korosoglou G, Giannitsis E, Katus HA. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011;97:727-732.
6. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-2743.
7. Marín RC, Ossaba VS, Maroto AE, Sánchez Alegre ML. Lack of MR late enhancement in left ventricular non-compaction in infants and young children. Radiologia 2010;52:138-143.
8. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112: e154-e235.
9. Stollberger C, Finsterer J, Blazek G, Bittner R. Left ventricular non-compaction in a patient with Beckers muscular dystrophy. Heart 1996;76:380.